5 Best Shares to Buy Right Now in Australia

Finding the best shares to buy on the ASX requires more than just scanning a screener or chasing whatever is up this week. We focus on companies with strong competitive positioning, visible earnings growth, and a catalyst to drive the share price higher over the next 12 months. Every stock on this list has been through a full research process covering financials, industry dynamics, valuation, and management quality.

We update this page regularly as new research is published. The five stocks below represent our most recent work, ordered from newest to oldest. Each summary covers the key points of the investment case, with a link to the full write-up for those who want the detail.

Last updated 17 November 2026.

Stock Rating Price Target Last Price Upside Div Yield
a2 Milk (ASX: A2M) Buy A$8.20 A$7.25 13.1% ~6.0%
Pinnacle Investment Management (ASX: PNI) Buy A$18.64 A$14.58 27.8% ~3.8%
BHP (ASX: BHP) Buy A$65.70 A$54.34 20.9% ~4.2%
Rio Tinto (ASX: RIO) Buy A$176.30 A$140.72 25.3% ~4.5%
Bellevue Gold (ASX: BGL) Buy A$1.90 A$1.44 31.9%
Table of contents [hideshow]

Our Top 5 Stocks To Buy Right Now on the ASX

a2 Milk (ASX: A2M)

Buy, 12-month price target A$8.20 (11.0% upside), ~6.0% dividend yield, fully franked. Rating and price target from institutional sell-side research; upside based on prices at time of publication.

The a2 Milk Company is a New Zealand company whose largest business is infant milk formula. It sells China label products, which are registered for sale in mainland China, and English label products led by the a2 Platinum range, and it also has a US business. It reports in New Zealand dollars, has a 30 June year end, and posted FY26 revenue of NZ$1,972.5 million. The China label business is being rebuilt after supply and availability problems with its Stage 1 product cost it early-stage customers. In August, China label offtake, meaning what parents actually buy, was running at about 40 per cent of pre-disruption levels, against a goal of 100 per cent by the end of FY27. Marketing as a share of sales has already climbed from 10.4 per cent in FY19 to 16.5 per cent in FY26, and the company has guided to more spending in the first half of FY27.

Two new China label formulas are priced at a premium of between 10 and 20 per cent to the existing product, a refreshed a2 Platinum is on the shelves, and the full new product slate is expected to add more than $400 million of incremental revenue between FY25 and FY30. Production of a2 Platinum is moving from Synlait into the company’s own Pokeno plant, which is expected to add about 160 basis points to the group EBITDA margin by FY30. Institutional sell-side research forecasts EBITDA rising from NZ$312.5 million in FY27 to NZ$402.9 million in FY28, growth of about 29 per cent.

The price target was lifted from A$7.40 as the valuation now looks to FY28 earnings, the year the China rebuild and Pokeno are expected to show up. The new 12 month target from institutional sell-side research is A$8.20, 11.0 per cent above the share price of A$7.39 when this research was published. a2 Milk has paid A$0.44 per share in dividends over the past twelve months, a trailing yield of 6.0 per cent, fully franked. The first half is expected to be weak, with the 1H27 margin forecast to fall 450 basis points, and a falling Chinese birth rate could shrink the infant formula market. The checkpoints are the AGM on 19 November and China label offtake climbing toward the 100 per cent target. Read the full article on a2 Milk here.

Pinnacle Investment Management (ASX: PNI)

Buy, 12-month price target A$18.64 (17.8% upside), ~3.8% dividend yield, 65% franked. Rating and price target from institutional sell-side research; upside based on prices at time of publication.

Pinnacle Investment Management is an Australian multi-affiliate investment manager. It holds interests in a group of specialist fund managers, including Antipodes, Metrics, Resolution and PAM, and earns its share of their earnings and distributions. Many of these affiliates are not controlled by Pinnacle, which keeps the business capital-light. Its first quarter update for fiscal 2027 showed affiliate funds under management up A$8.7 billion over the quarter to A$238.1 billion. Net flows of A$5.9 billion drove most of the result, just under the A$6.1 billion that had been forecast. Earnings per share were A$0.79 in fiscal 2026.

The company puts platform capacity at around A$850 billion, of which around A$600 billion is unused. That supports a forecast 13 per cent compound annual growth in funds under management to fiscal 2029, with earnings per share rising toward A$1.10 in that year. Around 80 per cent of funds sit at or near their high watermark, so a good run of returns could lift performance fees quickly. The soft area is private credit and real estate at Metrics and Resolution, where the company expects flows to come under pressure in the short term. Earnings forecasts have been trimmed by around 4 to 5 per cent to reflect it. International flows were also soft and fell once PAM is excluded.

The shares have fallen further than the broader small-cap market this financial year, and the bad news on Metrics is now reflected in lower forecasts. Institutional sell-side research has a 12 month price target of A$18.64, which is 17.8 per cent above the share price of A$15.83 when this research was published, after a cut from A$21.55. Pinnacle paid A$0.60 per share in dividends over the past twelve months, a trailing yield of 3.8 per cent. That dividend is partly franked at 65 per cent, so investors who can use franking credits, including SMSF trustees, receive extra value beyond the cash. The next couple of quarterly flow updates will show whether the soft patch is as short-lived as the company expects. Read the full article on Pinnacle Investment Management here.

BHP (ASX: BHP)

Buy, 12-month price target A$65.70 (14.1% upside), ~4.2% dividend yield, fully franked. Rating and price target from institutional sell-side research; upside based on prices at time of publication.

BHP is a diversified resources company listed on the ASX. It mines copper at Escondida and Spence in Chile, through Copper South Australia and through its interest in Antamina. It also runs the WAIO iron ore business in the Pilbara, the BMA metallurgical coal business and NSW Energy Coal, and it is building the Jansen potash project. Revenue was US$59,274 million in FY26, EBITDA was US$30,070 million and earnings per share were US$2.60. In the September quarter, the first of FY27, group copper production was about 401 thousand tonnes, around 10 per cent below sell-side estimates. Scheduled maintenance, severe weather in Chile, a conveyor failure at Carrapateena and safety stoppages all landed in the same three months. Iron ore and coal output made up the shortfall. WAIO produced about 71.9 million tonnes, a September quarter record at both mine and port, and coal output came in above expectations. All FY27 production and unit cost guidance was left unchanged.

A rules-based approach to leveraged ETFs

See how our quantitative strategy works and who it suits.

Explore the strategy

Become an authorised representative

Advise your clients under an established AFSL without building your own. Choose AR or CAR.

Become an AR or CAR

Sell-side research credits BHP with higher margins than its peers, and in Pilbara iron ore it generates more free cash flow per tonne, cash that helps fund a copper pipeline of about US$50 billion. It forecasts equity copper production rising to about 1.8 million tonnes from FY35, after a forecast low point in FY27. Jansen Stage 1 is 87 per cent complete and on track for first potash in mid-calendar 2027 at a cost of US$8.4 billion. Even with every copper project included, net debt should stay below US$10 billion, well within the company’s own ceiling of US$20 billion.

Institutional sell-side research has a 12 month price target of A$65.70, which is 14.1 per cent above the share price of A$57.56 when this research was published. The target moved up slightly from A$65.50 after the result, since guidance held and strong realised prices offset the copper miss. Earnings per share are forecast to dip to US$2.51 in FY27 before recovering to US$2.54 in FY29. BHP has paid about A$2.42 per share in dividends over the past twelve months, a trailing yield of 4.2 per cent, fully franked. The franking credits can reduce the tax an Australian shareholder, including an SMSF, pays on that dividend. Sell-side research expects BHP to maintain a 60 per cent payout ratio through the FY27 production dip. The main risks are weaker iron ore or copper prices, cost pressure and project delays. Read the full article on BHP here.

Rio Tinto (ASX: RIO)

Buy, 12-month price target A$176.30 (20.5% upside), ~4.5% dividend yield, fully franked. Rating and price target from institutional sell-side research; upside based on prices at time of publication.

Rio Tinto is a diversified miner listed on the Australian Securities Exchange, and its two biggest businesses are iron ore and copper. It runs the Pilbara iron ore system in Western Australia and the new Simandou mine in Guinea, owns the Oyu Tolgoi and Kennecott copper operations, and also has bauxite, alumina, aluminium and a lithium business in Argentina. The September quarter was in line with expectations. Group copper production was 205kt, and Oyu Tolgoi produced 114kt, up 27 per cent on a year earlier. Global iron ore sales were 90.8Mt, up 3 per cent, and Simandou reached an annualised production rate of around 10Mtpa. All 2026 production, sales and unit cost guidance was left unchanged, including 800 to 870kt of consolidated copper production.

Copper is forecast to deliver around 45 to 50 per cent of group EBITDA in 2026, rising to around 60 per cent by 2030. The research forecasts EBITDA to grow by around 30 per cent from 2025 to 2030 as Oyu Tolgoi, Simandou and the Pilbara replacement mines ramp up. Simandou is close to first ore through its port, and the 60Mtpa run-rate in the second half of 2028 was reaffirmed. Rio Tinto is also selling non-core assets. It has announced more than US$2 billion of capital release so far this year and is on track for around US$5 billion by the end of 2026, cash that can help pay down debt. EBITDA is forecast to ease to US$25,303.7 million in 2027, the year lower gold grades at Oyu Tolgoi, falling molybdenum output and Pilbara port works all land.

The shares closed at A$146.27. Institutional sell-side research has a 12 month price target of A$176.30, which is 20.5 per cent above that close. The target was trimmed by about 1 per cent from A$178.60 after small forecast cuts to reflect the result, lithium prices and higher net debt, and the rating is unchanged. Earnings per share are forecast at US$7.87 for 2026, against US$6.70 in 2025. The trailing dividend of about A$6.63 per share is a 4.5 per cent yield, and it is fully franked, so an Australian resident who can use the franking credits gets more after tax than the cash amount alone. The main risks are commodity prices, heritage approvals in the Pilbara, which is around 50 per cent of the group’s value, and delays to growth projects. The thesis depends on growth over several years, with the fully franked yield providing income in the meantime. Read the full article on Rio Tinto here.

Bellevue Gold (ASX: BGL)

Buy, 12-month price target A$1.90 (32.9% upside). Rating and price target from institutional sell-side research; upside based on prices at time of publication.

Bellevue Gold is an Australian gold producer listed on the ASX. It runs a high-grade underground mine that feeds its own processing plant, which has an expanded capacity of 1.35 million tonnes a year. In FY26 it reported revenue of A$576.3 million and underlying EBITDA of about A$238 million, ahead of market expectations, at a margin of about 41 per cent. The beat came from lower corporate costs. Statutory net profit was much smaller at about A$7 million. Cash and gold on hand totalled about A$206 million, leaving net cash of about A$106 million after A$100 million of debt. FY27 guidance is unchanged at 150,000 to 170,000 ounces at an all-in sustaining cost of A$2,800 to A$3,100 an ounce, even though a slow change of mining contractor means the September quarter will come in below plan.

Bellevue Gold sold gold forward at an average price of A$3,004 an ounce, and its remaining hedges sit at roughly half of spot. That is why near-term free cash flow looks thin and why the shares have lagged some key peers. The company has been delivering into its hedges ahead of schedule, has no contractual deliveries due until the fourth quarter of FY27, and aims to clear the book by the end of FY27. Once it does, more of every ounce is sold at the market price. EBITDA is forecast to rise from A$237.5 million in FY26 to A$348.6 million in FY27 and A$593.3 million in FY28, the first full year of largely unhedged sales. The company also has spare plant capacity and has lifted exploration, with about 30 per cent of underground drilling metres now aimed at resource definition and exploration. The base forecasts include no extra ounces from either. The Ore Reserve fell to 1.0 million ounces from 1.3 million ounces, so the drilling has to rebuild it.

The shares closed at A$1.43, and the forecasts already include both the hedge drag and the soft September quarter. Only FY27 was revised. FY28 and FY29 revenue and EBITDA forecasts were left unchanged, because the contractor problem cost ounces in one quarter rather than lowering the mine plan. Institutional sell-side research has a 12 month price target of A$1.90, which is 32.9 per cent above that close. The target was trimmed by about 3 per cent from A$1.95 after the result. The board did not declare a final FY26 dividend, so returns depend on capital growth. The main risks are a fall in the gold price, a contractor handover that takes longer to settle, and exploration that fails to rebuild the reserve. Read the full article on Bellevue Gold here.

How We Pick Stocks for This List

Our selection process draws on institutional-grade research combined with our own analysis of each company’s competitive positioning, earnings trajectory, and valuation. We focus on ASX-listed businesses with clear catalysts, strong or improving returns on capital, and management teams with a track record of execution. Every stock on this list carries a Buy rating with a defined price target and investment thesis.

We are not trying to pick the next speculative runner. The companies featured here are profitable, have established market positions, and offer a risk-reward profile that we think makes sense for investors looking to build long-term wealth through Australian equities. We refresh this list as new research is completed, typically every few weeks.

If you would like to discuss any of these names, request a callback or call us on 1300 889 603.

Learn to trade with a plan

Our free 5-day course covers entries, exits and risk management.

Become an authorised representative

Advise your clients under an established AFSL without building your own. Choose AR or CAR.

Become an AR or CAR

This is general advice only. MF & Co Asset Management has not considered your personal financial needs, objectives or current situation. This information is not an offer, solicitation, or a recommendation for any financial product unless expressly stated. You should seek professional investment advice before making any investment decision.

You May Also Like…

« Older Entries

Unlock every article for free

Become an authorised representative

Advise your clients under an established AFSL without building your own. Choose AR or CAR.

Become an AR or CAR

MF & Co. Asset Management

MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.

We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.